Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues

Trial Profile

Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 04 May 2018

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Cluster headache
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Apr 2018 Planned End Date changed from 1 Jun 2018 to 1 Dec 2019.
    • 30 Apr 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2019.
    • 06 Apr 2018 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top